Biogen To Take Over Nightstar Therapeutics In $877M Deal Nightstar
Therapeutics to be bought by Biogen for its pipeline of gene therapies
worth $877 million. This huge takeover will provide Biogen management
of clinical-phase ophthalmology resources that could get to market
ahead of drugs in development in rival gene therapy shops. After
spinning out from Oxford University […]
The post Biogen To Take Over Nightstar Therapeutics In $877M Deal
appeared first on BioTecNika .
https://www.biotecnika.org/2019/03/biogen-take-over-nightstar-therapeutics/
Biotech News
No comments:
Post a Comment